A NONHUMAN PRIMATE MODEL OF RICKETTSIA PROWAZEKII INFECTION (EPIDEMIC TYPHUS)
A NONHUMAN PRIMATE MODEL OF RICKETTSIA PROWAZEKII INFECTION (EPIDEMIC TYPHUS)
批准号:
7562382
负责人:
CHAD J. ROY
金额:
$3.04万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-05-01 至 2008-04-30
关键词:
BiologicalCharacteristicsChinese PeopleClinicalComputer Retrieval of Information on Scientific Projects DatabaseDevelopmentDiseaseDisease modelDoseEnvironmentEpidemicFeverFundingGoalsGrantHumanImmune responseInfectionInstitutionLiceMacaca mulattaModelingNeuraxisNodulePathologicPathologyPrimatesResearchResearch PersonnelResourcesRickettsia prowazekiiSafetySourceSymptomsSyndromeSystemTestingTyphusUnited States National Institutes of HealthVaccinesVasculitisbasemodel developmentnonhuman primateresponsevaccine efficacyvector
中文摘要
这个子项目是许多研究子项目中利用
资源由NIH/NCRR资助的中心拨款提供。子项目和
调查员(PI)可能从NIH的另一个来源获得了主要资金,
并因此可以在其他清晰的条目中表示。列出的机构是
该中心不一定是调查人员的机构。
普氏立克次体是流行性斑疹伤寒的病原体,斑疹伤寒是一种媒介(虱子)传播的疾病,其特征是突然出现发热症状,并有显著的病理后遗症。除了在恶劣和不卫生的环境中引起流行病外,普罗瓦泽克杆菌还被确认具有生物武器的特征。尽管目前正在开发新产品,但目前还没有预防流行性斑疹伤寒的疫苗。需要一个完全表征疾病的灵长类动物模型来确定免疫反应、安全性和疫苗产品的保护效力,以防止普罗瓦泽克杆菌感染。该项目的目标是开发一种针对流行性斑疹伤寒的强大的非人类疾病模型,以加快对新开发的疫苗产品的测试。具体的假设是,使用起源于中国的恒河猴(Macaca Mulatta)将为流行性斑疹伤寒的感染模型提供一个最佳的测试系统。我们基于对过去有限研究的观察,这些研究详细说明了1)在使用恒河猴与实验感染无毒菌株进行直接比较时,先前使用恒河猴进行的Blinl株模型开发工作中明确的剂量-反应关系,以及2)典型的病理形式,包括模仿人类临床综合征的中枢神经系统中的斑疹伤寒结节。基于这些观察,这项建议的实验重点是在恒河猴中建立流行性斑疹伤寒的模型。
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Rickettsia prowazekii is the causative agent of epidemic typhus, a vector (louse)-borne disease characterized by a sudden onset of febrile symptoms with significant pathologic sequelae. In addition to causing epidemic disease in poor and unhygienic environments, R. prowazekii has also been identified as possessing the characteristics of a biological weapon. There presently is no vaccine available for protection against epidemic typhus, although development of new products is currently underway. A fully characterized primate model of disease is needed to determine immune response, safety, and protective efficacy of vaccine products developed to protect against R. prowazekii infection. The goal of this project is to develop a robust nonhuman model of disease for epidemic typhus in order to accelerate testing of newly developed vaccine products. The specific hypothesis is that use of the Rhesus macaque (Macaca mulatta) of Chinese origin will provide an optimal test system for an infection model of epidemic typhus. We base this hypothesis upon the observations from limited past studies that detailed 1) a clear dose-response relationship in prior model development efforts with the Breinl strain using Rhesus macaques when directly compared to experimental infection with avirulent strains, and 2) typical pathology in the form of disseminated vasculitis including typhus nodules in the central nervous system that emulated the human clinical syndrome. Based on these observations, the experimental focus of this proposal is on the model development of epidemic typhus in the Rhesus macaque.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HUMAN ANTIBODIES FOR THERAPEUTIC INTERVENTION OF SEB EXPOSURE
-
批准号:8358109
-
项目类别:
-
资助金额:$3.72万
-
财政年份:2011
-
负责人:CHAD J. ROY
-
依托单位:
NONHUMAN PRIMATE MODEL OF MELIODOSIS
-
批准号:8358092
-
项目类别:
-
资助金额:$3.72万
-
财政年份:2011
-
负责人:CHAD J. ROY
-
依托单位:
CONTINUED DEVELOPMENT OF RIVAX VACCINE FOR RICIN
-
批准号:8358110
-
项目类别:
-
资助金额:$3.72万
-
财政年份:2011
-
负责人:CHAD J. ROY
-
依托单位:
INFECTIOUS DISEASE AEROBIOLOGY CORE
-
批准号:8358141
-
项目类别:
-
资助金额:$3.72万
-
财政年份:2011
-
负责人:CHAD J. ROY
-
依托单位:
VACCINE DEVELOPMENT FOR ALPHAVIRUSES
-
批准号:8358111
-
项目类别:
-
资助金额:$3.72万
-
财政年份:2011
-
负责人:CHAD J. ROY
-
依托单位:
POSTEXPOSURE PROPHYLAXIS AND TREATMENT OF AEROSOLIZED SMALLPOX
-
批准号:8358129
-
项目类别:
-
资助金额:$3.72万
-
财政年份:2011
-
负责人:CHAD J. ROY
-
依托单位:
A NONHUMAN PRIMATE MODEL OF RICKETTSIA PROWAZEKII INFECTION (EPIDEMIC TYPHUS)
-
批准号:8173017
-
项目类别:
-
资助金额:$6.18万
-
财政年份:2010
-
负责人:CHAD J. ROY
-
依托单位:
POSTEXPOSURE PROPHYLAXIS AND TREATMENT OF AEROSOLIZED SMALLPOX
-
批准号:8173041
-
项目类别:
-
资助金额:$6.18万
-
财政年份:2010
-
负责人:CHAD J. ROY
-
依托单位:
NONHUMAN PRIMATE MODEL OF MELIODOSIS
-
批准号:8172994
-
项目类别:
-
资助金额:$6.18万
-
财政年份:2010
-
负责人:CHAD J. ROY
-
依托单位:
VACCINE DEVELOPMENT FOR ALPHAVIRUSES
-
批准号:8173021
-
项目类别:
-
资助金额:$6.18万
-
财政年份:2010
-
负责人:CHAD J. ROY
-
依托单位:
HUMAN ANTIBODIES FOR THERAPEUTIC INTERVENTION OF SEB EXPOSURE
-
批准号:8173018
-
项目类别:
-
资助金额:$6.18万
-
财政年份:2010
-
负责人:CHAD J. ROY
-
依托单位:
INFECTIOUS DISEASE AEROBIOLOGY CORE
-
批准号:8173055
-
项目类别:
-
资助金额:$6.18万
-
财政年份:2010
-
负责人:CHAD J. ROY
-
依托单位:
MONOCLONAL ANTIBODY SEB IMMUNOPROTECTANT
-
批准号:8173019
-
项目类别:
-
资助金额:$6.18万
-
财政年份:2010
-
负责人:CHAD J. ROY
-
依托单位:
CONTINUED DEVELOPMENT OF RIVAX VACCINE FOR RICIN
-
批准号:8173020
-
项目类别:
-
资助金额:$6.18万
-
财政年份:2010
-
负责人:CHAD J. ROY
-
依托单位:
EFFICACY OF FLAGELLIN/F1/V MUCOSAL PLAGUE VACCINE IN C MACAQUES AND C AETHIOPS
-
批准号:7958704
-
项目类别:
-
资助金额:$5.8万
-
财政年份:2009
-
负责人:CHAD J. ROY
-
依托单位:
MONOCLONAL ANTIBODY SEB IMMUNOPROTECTANT
-
批准号:7958707
-
项目类别:
-
资助金额:$5.8万
-
财政年份:2009
-
负责人:CHAD J. ROY
-
依托单位:
A NONHUMAN PRIMATE MODEL OF RICKETTSIA PROWAZEKII INFECTION (EPIDEMIC TYPHUS)
-
批准号:7958705
-
项目类别:
-
资助金额:$5.8万
-
财政年份:2009
-
负责人:CHAD J. ROY
-
依托单位:
MELIODOSIS
-
批准号:7958676
-
项目类别:
-
资助金额:$5.8万
-
财政年份:2009
-
负责人:CHAD J. ROY
-
依托单位:
CONTINUED DEVELOPMENT OF RIVAX VACCINE FOR RICIN
-
批准号:7958708
-
项目类别:
-
资助金额:$5.8万
-
财政年份:2009
-
负责人:CHAD J. ROY
-
依托单位:
VACCINE DEVELOPMENT FOR ALPHAVIRUSES
-
批准号:7958709
-
项目类别:
-
资助金额:$5.8万
-
财政年份:2009
-
负责人:CHAD J. ROY
-
依托单位:
海外基金